Request Demo
Pharmaceutical Insights
Navigate pharmaceutical trends with our insights on targets, institutional pipelines, clinical advances, and new drugs.
Recent blog posts
9 min read
SSGJ-716 in Dermatitis, Atopic: NCT07693738 Clinical Landscape Report 2026
16 September 2026
NCT07693738 clinical landscape for Dermatitis, Atopic: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Menthol in Dermatitis, Atopic: NCT07693400 Clinical Landscape Report 2026
16 September 2026
NCT07693400 clinical landscape for Dermatitis, Atopic: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Disitamab Vedotin in HER2-Expressing Non-Muscle Invasive Bladder Neoplasms: NCT07693959 Clinical Landscape Report 2026
16 September 2026
NCT07693959 clinical landscape for HER2-Expressing Non-Muscle Invasive Bladder Neoplasms: endpoints, sponsor, phase, geography, readouts, asset context and d…
9 min read
ARC-02 in B-Cell Lymphoma: NCT07691606 Clinical Landscape Report 2026
16 September 2026
NCT07691606 clinical landscape for B-Cell Lymphoma: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Pembrolizumab in Ewing Sarcoma: NCT07695311 Clinical Landscape Report 2026
16 September 2026
NCT07695311 clinical landscape for Ewing Sarcoma: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Aldesleukin in Metastatic melanoma: NCT07700121 Clinical Landscape Report 2026
16 September 2026
NCT07700121 clinical landscape for Metastatic melanoma: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Upadacitinib hemihydrate in Colitis, Ulcerative: ACTRN12626000839303 Clinical Landscape Report 2026
16 September 2026
ACTRN12626000839303 clinical landscape for Colitis, Ulcerative: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
HRS-8797 in Dermatitis, Atopic: NCT07698756 Clinical Landscape Report 2026
16 September 2026
NCT07698756 clinical landscape for Dermatitis, Atopic: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
LCA-0061 in Peanut Hypersensitivity: NCT07701954 Clinical Landscape Report 2026
16 September 2026
NCT07701954 clinical landscape for Peanut Hypersensitivity: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Empagliflozin in Lupus Nephritis: NCT07700940 Clinical Landscape Report 2026
16 September 2026
NCT07700940 clinical landscape for Lupus Nephritis: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Upadacitinib hemihydrate in Colitis, Ulcerative: NCT07700446 Clinical Landscape Report 2026
16 September 2026
NCT07700446 clinical landscape for Colitis, Ulcerative: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Ruxolitinib Phosphate in Dermatitis, Atopic: CTRI/2026/07/114147 Clinical Landscape Report 2026
16 September 2026
CTRI/2026/07/114147 clinical landscape for Dermatitis, Atopic: endpoints, sponsor, phase, geography, readouts, asset context and development white space.